Tian'an Technology (TANAF) Receivables (2023 - 2025)

Tian'an Technology (TANAF) posted Receivables of $17537.0 for Q4 2025, down 80.79% on a QoQ basis from $91301.0 in Q2 2025, and up 19.85% year-over-year from $14632.0 in Q4 2024.

Tian'an Technology (TANAF) has 3 years of Receivables data on file, last reported at $17537.0 in Q4 2025.

  • In Q4 2025, Receivables rose 19.85% year-over-year to $17537.0; the TTM figure through Dec 2025 stood at $17537.0 (up 19.85% YoY), while the FY2025 annual figure was $17537.0, up 19.85% from the prior year.
  • Receivables retreated to $17537.0 in Q4 2025, from $91301.0 in the prior quarter.
  • Across five years, Receivables topped out at $91301.0 in Q2 2025 and bottomed at $635.0 in Q4 2023.
  • A 3-year average of $27264.2 and a median of $16084.5 in 2024 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2024 — Receivables plunged 93.34% — and 2025, when it jumped 3602.39%.
  • Year by year, Receivables stood at $635.0 in 2023, then jumped by 2204.25% to $14632.0 in 2024, then advanced by 19.85% to $17537.0 in 2025.
  • The last three Receivables figures came in at $17537.0 (Q4 2025), $91301.0 (Q2 2025), and $14632.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.21 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.36 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.15 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 973.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.82 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.11 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 4.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.09 Bn
10 Tian'an Technology - - - 17,537.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 17,537.00
Jun 30, 2025 91,301.00
Dec 31, 2024 76,272.00
Jun 30, 2024 2,466.00
Dec 31, 2023 3,253.00
Jun 30, 2023 -37,279.00